Anuloma Viloma Timer
International Men’s Health Week opens today. The Global Action on Men’s Health frame, “Partners in Care: Advancing Men’s Health Through Connection, Education, and Advocacy,” runs alongside US Men’s Health Week through Sunday. This Thursday at Altnagelvin, the Macmillan Support Centre at Western Health hosts a free breathwork session. NHS-adjacent men’s health programming. That is the calendar around a small but important clinical paper.
Mittal and colleagues, Annals of Neuroscience, April 2025. The trial recruited adults with hypertension who were already on standard pharmacological therapy. Half were assigned to continue medication alone. Half added ten minutes of daily anulom-vilom pranayama, alternate nostril breathing, the same practice traditional yoga texts describe and modern clinics are now quietly recommending. Six weeks of follow-up. Systolic blood pressure dropped. Diastolic blood pressure dropped. Heart rate variability autonomic parameters improved. Effects were measured immediately after a session and sustained across the six-week window.
The framing matters. Hypertension trials usually compare a new intervention against placebo or against no treatment. Mittal’s group ran the harder test: standard care versus standard care plus breath. The medication was not removed. The breath was layered on top. The numbers fell anyway.
The paper names the practice explicitly. The abstract uses the term “Anulom-vilom pranayama.” Not “controlled breathing.” Not “slow paced breathing.” Not “diaphragmatic breath.” Anulom-vilom. Same practice. Same Sanskrit name. The same one that appears in the Hatha Yoga Pradipika, attributed to Svatmarama in the 15th century, drawing on a Sanskrit tradition more than two thousand years older. The clinical literature is converging on the Sanskrit term because the Sanskrit term is the most precise.
Pause on what that means at the population level. Globally, more than a billion adults live with elevated blood pressure. A meaningful share of them are on medication that lowers numbers but does not address autonomic tone. The Mittal trial suggests a complementary lever exists. Not a replacement for the medication. A complement. Ten minutes a day. Free, structured, non-pharmacological.
The mechanism is no longer mysterious. Slow paced nasal breathing at roughly six breaths per minute, the resonance frequency studied by King’s College London in a separate 2025 trial of 135 adults with generalized anxiety disorder, lifts HRV and improves inhibitory control. The autonomic shift is measurable. Apple Watch users will recognize this directly: the wrist measures heart rate in real time, HRV downstream from that, and a slow nasal practice moves both. Different practice families produce different autonomic signatures. Box breathing flattens. Cyclic sighing reduces stress in single short sessions. Anulom-vilom lateralises the breath across both nostrils with a held pause in between, balancing left and right autonomic outflow. The held pause has a name: kumbhaka.
For the men reading this during their own Men’s Health Week: the trial speaks directly to you. Hypertension is the leading cardiovascular risk factor in men over 40. Medication compliance is high but adjunct lifestyle tools are rarely prescribed beyond exercise and diet. A six-week pranayama trial that moves both blood pressure numbers in patients already on hypertensives belongs in the conversation. The Altnagelvin clinic session on Thursday is one signal that the clinical community has noticed. The Mittal paper is the data behind that signal.
Practical notes for trying this. Anulom-vilom is performed seated, spine tall. Inhale slowly through the left nostril while gently closing the right. Hold for a brief kumbhaka pause. Exhale slowly through the right nostril while closing the left. Inhale right. Brief pause. Exhale left. That is one cycle. The Mittal trial used ten minutes per day. The King’s College resonance frequency study used six breaths per minute. A simple timer that paces inhale, hold, and exhale removes the need for counting and frees the practitioner to attend to the breath itself.
Two cautions worth noting. First, the trial population was already medicated. Anyone with diagnosed hypertension should continue prescribed care and discuss adjunct practices with their physician. Second, the immediate effects are small per session. The six-week sustained effects compound. Daily practice is the variable that matters.
A note on positioning. The wider wellness market this year has rushed into branded breathwork: cardiac coherence, cyclic sighing, box breathing, the latest renamed protocol. Each has its place. None of them have a 15th-century Sanskrit primary source and a 2025 randomized trial that adds a measurable adjunct effect on top of standard hypertension medication. The practice with both the lineage and the trial data is anulom-vilom. The trial is open access. The Sanskrit name is open access. The technique is free to learn and free to practice.
International Yoga Day arrives Sunday on the 21st, six days from today, with the theme “Yoga for Healthy Ageing.” Cardiovascular ageing is the most common form of ageing badly. A six-week trial that helps medicated patients lower both blood pressure numbers is a Yoga for Healthy Ageing data point.
Anuloma Viloma Timer is free on the App Store. No subscription necessary.